Search results
Jump to navigation
Jump to search
Page title matches
- * [[mercaptopurine]] is an "antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesi ...ally acute non-lymphoblastic [[leukemia]]. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phas10 KB (1,356 words) - 06:07, 5 April 2024
- 115 bytes (14 words) - 03:06, 7 September 2009
- 4 KB (467 words) - 00:17, 6 February 2009
Page text matches
- An [[antineoplastic agent]], of the [[nitrogen mustard]] family of [[alkylating agent]]s, used as a s204 bytes (27 words) - 15:37, 5 February 2009
- An [[antineoplastic agent]] of the miscellaneous [[alkylating agent]] category, used against [[melano142 bytes (15 words) - 08:35, 5 February 2009
- #REDIRECT [[Antineoplastic agent]]34 bytes (3 words) - 11:34, 23 March 2010
- A [[monoclonal antibody]] used as an [[antineoplastic agent]]97 bytes (11 words) - 12:24, 17 July 2010
- A [[pyrimidine]] analog chemical used as an [[antineoplastic agent]]104 bytes (12 words) - 14:20, 4 August 2010
- ...is a [[medication]] that is "precursor of an alkylating nitrogen mustard [[antineoplastic agent|antineoplastic ]] and [[immunosuppressive agent]] that must be activated in557 bytes (72 words) - 03:02, 7 October 2013
- An [[antineoplastic agent]] used for [[palliative]] treatment of [[chronic lymphocytic leukemia]]133 bytes (14 words) - 18:10, 11 April 2009
- [[Cancer|Antineoplastic agent]] [[antibody]] that blocks [[epidermal growth factor]] (EGF) [[receptor]]s149 bytes (16 words) - 11:35, 4 December 2010
- The growth of new blood vessels; [[angiogenesis inhibitor]]s are [[antineoplastic agent]]s127 bytes (16 words) - 19:02, 17 July 2010
- ...rimidine]] nucleoside analog that inhibits [[DNA]] synthesis, used as an [[antineoplastic agent]], [[antiviral]] and [[immunosuppressant]].181 bytes (19 words) - 07:51, 5 February 2009
- '''Dacarbazine''' is an [[antineoplastic agent]] considered a miscellaneous antialkylating agent, used for [[melanoma]] a270 bytes (31 words) - 23:52, 1 July 2010
- <noinclude>{{Subpages}}</noinclude>An antineoplastic agent that uses a [[monoclonal antibody]] to deliver radioisotopes to cancer cell135 bytes (17 words) - 00:53, 1 November 2010
- A [[antineoplastic agent]], of the [[monoclonal antibody]] class, directed against the CDw52 antigen165 bytes (20 words) - 09:14, 5 February 2009
- ...converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are used as [[antineoplastic agent]]s and [[immunosuppressant]]s215 bytes (25 words) - 00:17, 6 February 2009
- A drug that inhibits the growth of new blood vessels, typically an [[antineoplastic agent]] intended to reduce blood flow to a [[neoplasm]]175 bytes (25 words) - 18:59, 17 July 2010
- [[Antimetabolite]] antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesi317 bytes (39 words) - 20:14, 14 February 2010
- ...molecules and thereby prevent their proper functioning. Many are used as [[antineoplastic agent]]s, but most are very toxic, with [[carcinogen|carcinogenic]], [[mutagen|mu373 bytes (44 words) - 19:49, 7 February 2009
- ...inogenic, but derivatives, including the [[anthracycline]]s, are used as [[antineoplastic agent]]s242 bytes (33 words) - 14:46, 17 August 2010
- An [[antineoplastic agent]], principally used for [[Hodgkin's disease]] and [[non-Hodgkin's lymphoma]217 bytes (26 words) - 15:59, 5 February 2009
- '''Thiotepa''' is an [[antineoplastic agent]] of the [[alkylating agent]] class. Belonging to the [[nitrogen mustard]]1 KB (147 words) - 15:34, 5 February 2009
- ...[[chemical weapon]]s but found to have medical uses including acting as [[antineoplastic agent]]s.647 bytes (77 words) - 17:05, 22 June 2009
- {{r|Antineoplastic agent}}835 bytes (102 words) - 17:24, 11 January 2010
- {{r|Antineoplastic agent}}403 bytes (39 words) - 15:00, 27 May 2010
- {{r|Antineoplastic agent}}355 bytes (39 words) - 02:46, 21 March 2024
- ...especially acute non-lymphoblastic [[leukemia]]. It is an antimetabolite [[antineoplastic agent]] that inhibits the synthesis of DNA. Its actions are specific for the S ph467 bytes (61 words) - 02:25, 7 October 2013
- ...originally introduced as [[chemical weapon]]s but now used medically as [[antineoplastic agent]]s and [[immunosuppressant]]s. <ref>{{MeSH}}</ref>670 bytes (83 words) - 20:14, 1 July 2010
- {{rpl|Antineoplastic agent}}374 bytes (41 words) - 12:15, 17 May 2023
- {{r|Antineoplastic agent}}441 bytes (55 words) - 18:24, 11 January 2010
- {{r|Antineoplastic agent}}437 bytes (55 words) - 15:49, 11 January 2010
- {{r|Antineoplastic agent}}473 bytes (60 words) - 15:49, 11 January 2010
- {{r|Antineoplastic agent}}457 bytes (58 words) - 21:04, 11 January 2010
- {{r|Antineoplastic agent}}458 bytes (58 words) - 20:58, 11 January 2010
- {{r|Antineoplastic agent}}457 bytes (58 words) - 19:36, 11 January 2010
- {{r|Antineoplastic agent}}495 bytes (62 words) - 16:35, 11 January 2010
- {{r|Antineoplastic agent}}486 bytes (62 words) - 15:48, 11 January 2010
- {{r|Antineoplastic agent}}525 bytes (65 words) - 19:02, 11 January 2010
- {{r|Antineoplastic agent}}606 bytes (75 words) - 20:04, 11 January 2010
- {{r|Antineoplastic agent}}647 bytes (82 words) - 18:12, 11 January 2010
- {{r|Antineoplastic agent}}640 bytes (83 words) - 18:38, 11 January 2010
- {{r|Antineoplastic agent}}658 bytes (81 words) - 19:48, 11 January 2010
- In [[medicine]], [[fludarabine]] is a [[medication]] that is a [[antineoplastic agent]]. It is approved by the U.S. Food and Drug Administration for the palliati638 bytes (88 words) - 02:54, 10 February 2010
- {{r|Antineoplastic agent}}652 bytes (83 words) - 18:28, 11 January 2010
- 797 bytes (95 words) - 18:40, 7 July 2011
- {{r|Antineoplastic agent}}698 bytes (86 words) - 15:48, 11 January 2010
- In [[oncology]], '''etoposide''' is a [[antineoplastic agent]] that is a "semisynthetic derivative of podophyllotoxin that exhibits anti601 bytes (86 words) - 08:15, 30 September 2009
- {{r|Antineoplastic agent}}751 bytes (96 words) - 11:59, 11 January 2010
- {{r|Antineoplastic agent}}687 bytes (86 words) - 19:46, 11 January 2010
- {{r|Antineoplastic agent}}847 bytes (107 words) - 15:32, 11 January 2010
- {{r|Antineoplastic agent}}884 bytes (109 words) - 19:35, 11 January 2010
- {{r|Antineoplastic agent}}828 bytes (107 words) - 22:30, 17 April 2011
- ...cause it. Leukopenia is common as a result of cancer chemotherapy with [[antineoplastic agent]]s.931 bytes (139 words) - 14:55, 6 August 2010
- {{r|Antineoplastic agent}}958 bytes (113 words) - 15:14, 18 January 2010
- {{r|Antineoplastic agent}}770 bytes (94 words) - 23:36, 30 June 2010
- {{r|Antineoplastic agent}}1 KB (147 words) - 07:44, 8 January 2010
- {{r|Antineoplastic agent}}1 KB (151 words) - 23:49, 24 September 2010
- {{r|Antineoplastic agent}}1 KB (161 words) - 10:26, 8 April 2023
- ...es]]}}</ref>. It also, however, has been a starting point for developing [[antineoplastic agent]]s, especially the [[anthracycline]] agents, of which [[doxorubricin]] (Adr1 KB (174 words) - 14:58, 17 August 2010
- ...are present in traditional herbal medicines, and are being researched as [[antineoplastic agent]]s.2 KB (241 words) - 04:03, 20 August 2010
- In [[oncology]], '''carboplatin''' is a [[antineoplastic agent]] that is an "organoplatinum compound that possesses antineoplastic activit4 KB (489 words) - 08:06, 27 June 2010
- * [[mercaptopurine]] is an "antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesi ...ally acute non-lymphoblastic [[leukemia]]. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phas10 KB (1,356 words) - 06:07, 5 April 2024
- ...Sloan-Kettering Cancer Center]], no studies of sheep sorrel alone, as an antineoplastic agent, have been done.1 KB (194 words) - 22:25, 19 August 2010
- {{r|Antineoplastic agent}}2 KB (219 words) - 21:43, 11 January 2010
- ...etabolite fluoropyrimidine analog of the nucleoside pyrimidine, used as an antineoplastic agent but also as an immunomodulator in dermatology.2 KB (318 words) - 02:18, 7 April 2024
- In [[medicine]], '''cetuximab''' (se tux' i mab) is an [[antineoplastic agent]] that is "an [[antibody]] that blocks [[epidermal growth factor receptor|r3 KB (353 words) - 01:59, 23 September 2010
- ...vastin''' by [[Genentech]], a subsidiary of [[Roche Laboratories]] as an [[antineoplastic agent]].3 KB (376 words) - 14:53, 17 July 2010
- ...relatively low prevalence of the disease, there is less experience with [[antineoplastic agent]]s and [[biologic response modifier]]s. More successful chemotherapy has us3 KB (421 words) - 13:28, 8 August 2010
- As a primary [[antineoplastic agent]], [[fludarabine]] may be more effective than [[chlorambucil]].<ref name="p4 KB (497 words) - 22:05, 12 June 2010
- ...d of the war, they proved to be the basis of some of the first effective [[antineoplastic agent]]s for [[cancer]] [[chemotherapy]].6 KB (979 words) - 11:49, 2 February 2023
- Bleomycin and carboplatin are the most common adjuvant and palliative [[antineoplastic agent]]s. As with any cancer chemotherapy, the challenge is managing the toxicity11 KB (1,557 words) - 00:26, 9 September 2010
- '''<sup>90</sup>Yttrium-Ibritumomab Tiuxetan''' is an [[antineoplastic agent]] indicated for [[non-Hodgkin’s lymphom]]a. <sup>90</sup>Y-Ibritumomab Ti11 KB (1,563 words) - 03:38, 7 October 2013
- *[[Antineoplastic agent/Definition]]15 KB (1,521 words) - 09:02, 2 March 2024